BP4200: Recombinant Dr. Nuclease
Source: E. coli-derived.
Specific activity: ≥1.1 x 10^6 U/mg. One unit of Dr. Nuclease is defined as the amount of enzyme required to produce a change in absorbance at 260 nm of 1.0 in the time of 30 minutes, under optimum conditions with excess substrate.
Purity: ≥95% by SDS-PAGE and ≥99% by SEC-HPLC. It does not contain any antimicrobial preservatives or protein stabilizers except glycerol (of synthetic origin).BP4200-GMP: Recombinant Dr. Nuclease, GMP Grade
Source: E. coli-derived.
Predicted molecular mass: ~28 kDa.
Specific activity: ≥1.1 x 10^6 U/mg. One unit of Dr. Nuclease is defined as the amount of enzyme required to produce a change in absorbance at 260 nm of 1.0 in the time of 30 minutes, under optimum conditions with excess substrate.
Purity: ≥95% by SDS-PAGE and ≥99% by SEC-HPLC. It does not contain any antimicrobial preservatives or protein stabilizers except glycerol (of synthetic origin).
Formulation: 0.2 μM filtered solution (250 units/ul) of 20 mM Tris-HCl, pH 8.0, 2 mM MgCl2, 2 mM NaCl, 50% Glycerol.
Endotoxin level: ≤0.01 EU/1000 units following 2020 ChP 1143 USP <85>.
Protease activity: No detectable protease activity using casein as substrate.
Residual host cell protein: ≤10.0 ppm by ELISA.
Mycoplasma: negative by qPCR method.
Bioburden: negative following 2020 ChP 1105 USP <61>.
Residual heavy metal: ≤10.0 ppm following 2020 ChP 0821 USP <32>.PA007193: In vivo Grade Recombinant Chimeric Human IgG2 Isotype Control Antibody
Source: CHO cell-derived.
Applications: an isotype-matched negative control for human IgG2 kappa antibodies used in ELISA, Western Blot (WB), Flow Cytometry (Flow), Immunoprecipitation (IP), Immunohistochemistry (Paraffin) (IHC (P)), Immunohistochemistry (Frozen) (IHC (F)), and in vivo animal model research.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.BP001020-Z65: Recombinant Human transcription factor p65 protein
Source: Baculovirus, SF9 insect cells-derived.
Bioactivity test: 1 unit equals 1 nanogram of purified protein. 10 unit is sufficient for a gel mobility shift assay in a 20 ul reaction; 50 units are sufficient for reconstituted transcription assay and 100 units are sufficient for a protein-protein interaction assay.
Purity: > 90%, by SDS-PAGE.
Endotoxin Level: < 1.0 EU per 1 ug of the protein by the LAL method.APIM050318: DOXORUBICIN
CAS No.: 23214-92-8.
Purity: 99% (HPLC).
QC: HPLC, 1HNMR, Quantitative Elemental Analysis.
Solubility: Soluble in water.Sample requirement: 50-100 ug.
Fast turnaround time: 1 - 2 weeks.BP002639-CG08: Recombinant Human Myozenin-2 (MYOZ2) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000483-PRO-410: Dog Calsequestrin-2 (CASQ2) Protein
Source: Dog Heart-derived.
Purity: > 90% by SDS-PAGE.
Applications: Immunoblots, Absorption, Immunohistochemistry.BP000483-PRO-799: Recombinant Human Calsequestrin-2 (CASQ2) Protein
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP001620-ENZ-235: Recombinant Human Carbonic Anhydrase 8 (CA8) Enzyme
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP002680-PRO-009: Recombinant Human Kv Channel Interacting Protein 3 (KCNIP3) protein
Source: E. coli-derived.
Purity: > 90.0% by SDS-PAGE.